Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin

Agu, 2001, The lung as a route for systemic delivery of therapeutic proteins and peptides, Respir. Res., 2, 198, 10.1186/rr58 Bernkop-Schnürch, 2006, Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system, Int. J. Pharm., 317, 76, 10.1016/j.ijpharm.2006.02.044 Clark, 2008, A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin, Pharm. Res., 25, 1583, 10.1007/s11095-008-9547-x Dailey, 2003, Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features, J. Control. Release, 86, 131, 10.1016/S0168-3659(02)00370-X Deftos, 1997, Intrapulmonary drug delivery of salmon calcitonin, Calcif. Tissue Int., 61, 345, 10.1007/s002239900345 Grenha, 2005, Microencapsulated chitosan nanoparticles for lung protein delivery, Eur. J. Pharm. Sci., 25, 427, 10.1016/j.ejps.2005.04.009 Hinchcliffe, 2005, Effect of chitosan on the intranasal absorption of salmon calcitonin in rats, J. Pharm. Pharmacol., 57, 681, 10.1211/0022357056073 Kean, 2010, Biodegradation, biodistribution and toxicity of chitosan, Adv. Drug Deliv. Rev., 62, 3, 10.1016/j.addr.2009.09.004 Komada, 1994, Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lung, J. Pharm. Sci., 83, 863, 10.1002/jps.2600830621 Lauweryns, 1977, Alveolar clearance and the role of the pulmonary lymphatics, Am. Rev. Respir. Dis., 115, 625 Leitner, 2003, Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins, Eur. J. Pharm. Biopharm., 56, 207, 10.1016/S0939-6411(03)00061-4 Makhlof, 2010, A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa, J. Control. Release Morita, 1994, Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats, Pharm Res., 11, 909, 10.1023/A:1018950429341 Patton, 1994, Bioavailability of pulmonary delivered peptides and proteins: α-interferon, calcitonins and parathyroid hormones, J. Control. Release, 28, 79, 10.1016/0168-3659(94)90155-4 Patton, 1996, Mechanisms of macromolecule absorption by the lungs, Adv. Drug. Deliv. Rev., 19, 3, 10.1016/0169-409X(95)00113-L Patton, 2000, Pulmonary delivery of drugs for bone disorders, Adv. Drug. Deliv. Rev., 42, 239, 10.1016/S0169-409X(00)00064-8 Sakloetsakun, 2009, In situ gelling properties of chitosan–thioglycolic acid conjugate in the presence of oxidizing agents, Biomaterials, 30, 6151, 10.1016/j.biomaterials.2009.07.060 Scheuch, 2007, Novel approaches to enhance pulmonary delivery of proteins and peptides, J. Physiol. Pharmacol., 58, 615 Siekmeier, 2008, Systemic treatment by inhalation of macromolecules-principles, problems, and examples, J. Physiol. Pharmacol., 59, 53 Siekmeier, 2009, Treatment of systemic diseases by inhalation of biomolecule aerosols, J. Physiol. Pharmacol., 60, 15 Trapani, 2009, The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs, Int. J. Pharm., 375, 97, 10.1016/j.ijpharm.2009.03.041 Weissenböck, 2004, WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells, J. Control. Release, 99, 383, 10.1016/j.jconrel.2004.07.025 Werle, 2006, Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine, J. Control. Release, 111, 41, 10.1016/j.jconrel.2005.11.011 Yamamoto, 2001, Absorption of water-soluble compounds with different molecular weights and [Asu1,7]-eel calcitonin from various mucosal administration sites, J. Control. Release, 76, 363, 10.1016/S0168-3659(01)00454-0 Yamamoto, 2005, Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions, J. Control. Release, 102, 373, 10.1016/j.jconrel.2004.10.010 Yang, 2008, Inhaled nanoparticles – a current review, Int. J. Pharm., 356, 239, 10.1016/j.ijpharm.2008.02.011 Youn, 2008, Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection, J. Control. Release, 125, 68, 10.1016/j.jconrel.2007.10.008